NO20025303D0 - Anvendelse av substituerte akryloyl-distamycin-derivater i behandlingen av tumorer assosiert med höye nivÕer av glutation - Google Patents

Anvendelse av substituerte akryloyl-distamycin-derivater i behandlingen av tumorer assosiert med höye nivÕer av glutation

Info

Publication number
NO20025303D0
NO20025303D0 NO20025303A NO20025303A NO20025303D0 NO 20025303 D0 NO20025303 D0 NO 20025303D0 NO 20025303 A NO20025303 A NO 20025303A NO 20025303 A NO20025303 A NO 20025303A NO 20025303 D0 NO20025303 D0 NO 20025303D0
Authority
NO
Norway
Prior art keywords
sub
treatment
distamycin
glutathione
high levels
Prior art date
Application number
NO20025303A
Other languages
English (en)
Other versions
NO20025303L (no
Inventor
Maria Cristina Rosa Geroni
Paolo Cozzi
Italo Beria
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Publication of NO20025303L publication Critical patent/NO20025303L/no
Publication of NO20025303D0 publication Critical patent/NO20025303D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
NO20025303A 2000-05-08 2002-11-05 Anvendelse av substituerte akryloyl-distamycin-derivater i behandlingen av tumorer assosiert med höye nivÕer av glutation NO20025303D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0011059.3A GB0011059D0 (en) 2000-05-08 2000-05-08 Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione
PCT/EP2001/004470 WO2001085144A2 (en) 2000-05-08 2001-04-19 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione

Publications (2)

Publication Number Publication Date
NO20025303L NO20025303L (no) 2002-11-05
NO20025303D0 true NO20025303D0 (no) 2002-11-05

Family

ID=9891173

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025303A NO20025303D0 (no) 2000-05-08 2002-11-05 Anvendelse av substituerte akryloyl-distamycin-derivater i behandlingen av tumorer assosiert med höye nivÕer av glutation

Country Status (29)

Country Link
US (1) US7030089B2 (no)
EP (1) EP1280527B1 (no)
JP (1) JP2003532669A (no)
KR (1) KR100776184B1 (no)
CN (1) CN1258362C (no)
AR (1) AR029518A1 (no)
AT (1) ATE300944T1 (no)
AU (2) AU6022701A (no)
BR (1) BR0110628A (no)
CA (1) CA2409664C (no)
CZ (1) CZ300791B6 (no)
DE (1) DE60112423T2 (no)
DK (1) DK1280527T3 (no)
EA (1) EA007506B1 (no)
EE (1) EE200200605A (no)
ES (1) ES2244618T3 (no)
GB (1) GB0011059D0 (no)
HK (1) HK1054193B (no)
HU (1) HUP0301882A2 (no)
IL (2) IL152388A0 (no)
MX (1) MXPA02010962A (no)
NO (1) NO20025303D0 (no)
NZ (1) NZ522234A (no)
PL (1) PL201289B1 (no)
PT (1) PT1280527E (no)
SK (1) SK286501B6 (no)
TW (1) TWI284643B (no)
WO (1) WO2001085144A2 (no)
ZA (1) ZA200208531B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011059D0 (en) * 2000-05-08 2000-06-28 Pharmacia & Upjohn Spa Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione
GB0015446D0 (en) * 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl distamycin derivates,taxanes and/or antimetabolites
GB0015447D0 (en) 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl derivates and alkylating agents
GB0016447D0 (en) 2000-07-04 2000-08-23 Pharmacia & Upjohn Spa Process for preparing distamycin derivatives
IT1318696B1 (it) 2000-09-15 2003-08-27 Pharmacia & Upjohn Spa Coniugati di glutatione con derivati della distamicina ad attivita'antitumorale.
US6969592B2 (en) 2001-09-26 2005-11-29 Pharmacia Italia S.P.A. Method for predicting the sensitivity to chemotherapy
AU2003219102B2 (en) * 2002-04-02 2008-05-08 Nerviano Medical Sciences S.R.L. Combined therapy against tumors comprising subtituted acryloyl distamycin derivatives and radiotherapy
ES2867965T3 (es) * 2015-10-15 2021-10-21 Advanced Biodesign Compuestos de aminotioléster o sales farmacéuticamente aceptables de los mismos, para utilizar en el tratamiento del cáncer

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE468642B (sv) 1985-07-16 1993-02-22 Erba Farmitalia Poly-4-aminopyrrol-2-karboxamidoderivat och foerfarande foer deras framstaellning och en farmaceutisk komposition
GB8612218D0 (en) 1986-05-20 1986-06-25 Erba Farmitalia Site specific alkylating agents
IL84114A (en) 1986-10-07 1994-01-25 Boehringer Mannheim Italia Anti-neoplastic pharmaceutical compositions containing HSG together with an anti-tumor drug
GB8906709D0 (en) 1989-03-23 1989-05-10 Creighton Andrew M Acryloyl substituted pyrrole derivatives
JP2919867B2 (ja) 1989-09-27 1999-07-19 千寿製薬株式会社 抗腫瘍剤
IT1272234B (it) 1994-05-02 1997-06-16 Consiglio Nazionale Ricerche Derivati glutationici delle antracicline e procedimento per ottenerli.
GB9416005D0 (en) 1994-08-08 1994-09-28 Erba Carlo Spa Peptidic compounds analogous to distamycin a and process for their preparation
US5880097A (en) 1996-01-04 1999-03-09 Terrapin Techologies, Inc. Tethered prodrugs
EP0880499A1 (en) 1996-02-02 1998-12-02 PHARMACIA & UPJOHN S.p.A. Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
GB9610079D0 (en) 1996-05-14 1996-07-17 Pharmacia Spa Distamycin deriratives process for preparing them and their use as antitumor and antiviral agents
GB9615692D0 (en) * 1996-07-25 1996-09-04 Pharmacia Spa Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
GB9623522D0 (en) * 1996-11-11 1997-01-08 Pharmacia & Upjohn Spa Benzoheterocycle distamycin derivatives process for preparing them and their use as antitumour and antiviral agents
GB9727524D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Synergistic antitumor composition containing a biologically active ureido compound
GB9806689D0 (en) * 1998-03-27 1998-05-27 Pharmacia & Upjohn Spa Acryloyl derivatives analogous to distamycin,process for preparing them,and their use as antitumour and antiviral agents
GB9806692D0 (en) * 1998-03-27 1998-05-27 Pharmacia & Upjohn Spa Benzoheterocyclic distamycin derivatives, process for preparing them and their use as antitumour agents
GB9816653D0 (en) 1998-07-30 1998-09-30 Pharmacia & Upjohn Spa Oxidised sulfurated distamycin derivatives process for preparing them and their use as antitumor agents
GB9816652D0 (en) 1998-07-30 1998-09-30 Pharmacia & Upjohn Spa Sulfurated distamycin derivatives process for preparing them and their use as antitumor agents
GB9928703D0 (en) 1999-12-03 2000-02-02 Pharmacia & Upjohn Spa Acryloyl peptidic derivatives,process for their preparation and their use as antitumour agents
GB0011059D0 (en) * 2000-05-08 2000-06-28 Pharmacia & Upjohn Spa Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione

Also Published As

Publication number Publication date
EA200201184A1 (ru) 2003-04-24
BR0110628A (pt) 2003-03-18
WO2001085144A3 (en) 2002-05-16
DK1280527T3 (da) 2005-10-17
PL201289B1 (pl) 2009-03-31
HUP0301882A2 (hu) 2003-09-29
ZA200208531B (en) 2003-10-22
CN1427719A (zh) 2003-07-02
HK1054193A1 (en) 2003-11-21
IL152388A (en) 2008-04-13
DE60112423D1 (de) 2005-09-08
US20030207794A1 (en) 2003-11-06
DE60112423T2 (de) 2006-05-24
CZ20023629A3 (cs) 2003-03-12
AU6022701A (en) 2001-11-20
CZ300791B6 (cs) 2009-08-12
NO20025303L (no) 2002-11-05
GB0011059D0 (en) 2000-06-28
EP1280527A2 (en) 2003-02-05
ATE300944T1 (de) 2005-08-15
NZ522234A (en) 2004-09-24
CN1258362C (zh) 2006-06-07
HK1054193B (zh) 2007-02-02
EE200200605A (et) 2004-04-15
WO2001085144A2 (en) 2001-11-15
AU2001260227B2 (en) 2005-10-27
KR20030019371A (ko) 2003-03-06
TWI284643B (en) 2007-08-01
US7030089B2 (en) 2006-04-18
EA007506B1 (ru) 2006-10-27
IL152388A0 (en) 2003-05-29
PT1280527E (pt) 2005-10-31
CA2409664C (en) 2010-01-12
EP1280527B1 (en) 2005-08-03
MXPA02010962A (es) 2003-03-27
CA2409664A1 (en) 2001-11-15
PL365831A1 (en) 2005-01-10
KR100776184B1 (ko) 2007-11-16
ES2244618T3 (es) 2005-12-16
SK16002002A3 (sk) 2003-04-01
JP2003532669A (ja) 2003-11-05
AR029518A1 (es) 2003-07-02
SK286501B6 (sk) 2008-11-06

Similar Documents

Publication Publication Date Title
IS6565A (is) Trópan afleiður nytsamlegar í meðferð
JO2503B1 (en) Benzathiazole derivatives
ATE384058T1 (de) Thiazolderivate
EA200500304A1 (ru) Производные 3-(сульфонамидоэтил)индола, предназначенные для использования в качестве миметиков глюкокортикоидов при лечении воспалительных, аллергических и пролиферативных заболеваний
NO20055655L (no) Anvendelse av azetidinkarboksamidderivater i terapi
TR200101120T2 (tr) Serin proteaz inhibitörü
HK1070054A1 (en) Arylsulfonyl derivatives with5-ht6 receptor affinity
DE60121461D1 (de) Kondensierte pyridoindolderivate
NO20025303D0 (no) Anvendelse av substituerte akryloyl-distamycin-derivater i behandlingen av tumorer assosiert med höye nivÕer av glutation
MXPA05009282A (es) Derivados de anilina sustituidos.
DK1303307T3 (da) Kombinationsterapi mod tumorer omfattende substituerede acryloyldistamycinderivater og alkyleringsmidler
MXPA04005077A (es) Derivados de benzotiazol.
MXPA03003971A (es) Derivados de indol como inhibidores de pde5.
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
HUP0302255A2 (hu) Szulfonamidszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
NO20054086L (no) Depigmenteringsmidler